Correlation of the serum testosterone level with insulin resistance and metabolic syndrome in patients of erectile dysfunction and benign prostatic hyperplasia

Korean Journal of Urology

Volumn 49, Issue 6, 2008, Pages 556-561

  Lee, Seo Yeon ^a   Kim, Sae Chul ^a  

^a Chung Ang University   (South Korea)

Author keywords

Insulin resistance; Metabolic syndrome; Testosterone

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIOAVAILABILITY; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGONADISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PROSTATE HYPERTROPHY; RISK FACTOR; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 47249145949     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2008.49.6.556     Document Type: Article

References (30)

1. 2003 Cause of Death in Korea, The Department of Statistics. 2003;5
2. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyper-insulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34:416-22
3. Gray RS, Fabsitz RR, Cowan LD, Lee ET, Howard BV, Savage PJ. Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study. Am J Epidemiol 1998; 148:869-78
4. Carantoni M, Zuliani G, Volpato S, Palmieri E, Mezzetti A, Vergnani L, et al. Relationships between fasting plasma insulin, anthropometrics, and metabolic parameters in a very old healthy population. Associazione Medica Sabin. Metabolism 1998;47:535-40
5. Kalyani RR, Dobs AS. Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 2007;14:226-34
6. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000;23:490-4
7. Oh J, Barrett-Connor E, Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 2002;25:55-60
8. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;9:4335-43
9. Kapoor D, Malkin CJ, Charmer KS, Jones TH. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol 2005;63:239-50
10. Tan RS, Pu SJ. Impact of obesity on hypogonadism in the andropause. Int J Androl 2002;25:195-201
11. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 1990;132:895-901
12. Lunenfeld B. Testosterone deficiency and the metabolic syndrome. Aging Male 2007;10:53-6
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97
14. WHO Regional Office for the Western Pacific/International. Association for the Study of Obesity/International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney, Health Communications Australia, 2000
15. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9
17. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94
18. Kim SC. Insulin resistance and erectile dysfunction. Korean J Urol 2006;47:917-27
19. Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L, Bennett P, et al. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 2006;29:1591-8
20. Gustafson DR, Wen MJ, Koppanati BM. Androgen receptor gene repeats and indices of obesity in older adults. Int J Obes Relat Metab Disord 2003;27:75-81
21. Lacko L, Wittke B, Geck P. Interaction of steroids with the transport system of glucose in human erythrocytes. J Cell Physiol 1975;86(Suppl 2):673-80
22. Morimoto S, Mendoza-Rodriguez CA, Hiriat M, Larrieta ME, Vital P, Cerbon MA. Protective effect of testosterone on early apoptotic damange induced by streptozotocin in rat pancreas. J Endocrinol 2005;187:217-24
23. Hellmich M, Evers T, Kubin M, Merchant S, Lehmacher W, Engelmann U, et al. Development and validation of a risk score for somatic erectile dysfunction: combined results from three cross-sectional surveys. Eur Urol 2005;48:495-502
24. Kim JH, Shim BS, Hong YS. The relating factors of metabolic syndrome to benign prostatic hyperplasia. Korean J Urol 2005; 46:1046-50
25. Hammarsten J, Hogstedt B, Holthuis N, Mellstrom D. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1998;1:157-62
26. Hammarsten J, Hogstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press 1999;8:29-36
27. Braga-Basaria M, Dobs AS, Muller DC, Carducci MA, John M, Egan J, et al. The metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 2006;24:3979-83
28. Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006;24:448-56
29. Nuver J, Smit AJ, Wolffenbuttel BH, Sluiter WJ, Hoekstra HJ, Sleijfer DT, et al. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 2005;23:3718-25
30. Sampson N, Unterggasser G, Plas E, Berger P. The aging male reproductive tract. J Pathol 2007;211:206-18